Research and analysis

Impact assessment opinion: Transposition of Pharmacovigilance Directive 2010/84/EU

Evaluation of the Department of Health impact assessment for Transposition of Pharmacovigilance Directive 2010/84/EU

Documents

Impact assessment opinion: Transposition of Pharmacovigilance Directive 2010/84/EU

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email enquiries@bis.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Regulatory Policy Committee (RPC) gives independent advice to government on the quality of analysis supporting new regulations.

Following scrutiny of an impact assessment (IA) carried out prior to a regulatory proposal, the RPC provides an ‘opinion’ on the quality of analysis and evidence presented in the IA. This opinion then informs the decisions of ministers as to whether they proceed or not with the proposal.

Published 1 January 2013